Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
•Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls.•Higher IL-8 concentrations associated to lithium- and antipsychotic treatment.•Findings might reflect disease related immune aberrations or be due to medication.•Important to consider medication status while studyi...
Saved in:
Published in | Brain, behavior, and immunity Vol. 43; pp. 198 - 204 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
01.01.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0889-1591 1090-2139 1090-2139 |
DOI | 10.1016/j.bbi.2014.10.001 |
Cover
Abstract | •Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls.•Higher IL-8 concentrations associated to lithium- and antipsychotic treatment.•Findings might reflect disease related immune aberrations or be due to medication.•Important to consider medication status while studying the immune activity in BD.
Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication. |
---|---|
AbstractList | Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication. Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication.Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication. •Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls.•Higher IL-8 concentrations associated to lithium- and antipsychotic treatment.•Findings might reflect disease related immune aberrations or be due to medication.•Important to consider medication status while studying the immune activity in BD. Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication. Highlights • Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls. • Higher IL-8 concentrations associated to lithium- and antipsychotic treatment. • Findings might reflect disease related immune aberrations or be due to medication. • Important to consider medication status while studying the immune activity in BD. |
Author | Ekman, Carl Johan Jakobsson, Joel Pålsson, Erik Johansson, Anette G.M. Blennow, Kaj Zetterberg, Henrik Isgren, Anniella Sellgren, Carl Landén, Mikael |
Author_xml | – sequence: 1 givenname: Anniella surname: Isgren fullname: Isgren, Anniella email: anniella.isgren@vgregion.se organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden – sequence: 2 givenname: Joel surname: Jakobsson fullname: Jakobsson, Joel organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden – sequence: 3 givenname: Erik surname: Pålsson fullname: Pålsson, Erik organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden – sequence: 4 givenname: Carl Johan surname: Ekman fullname: Ekman, Carl Johan organization: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden – sequence: 5 givenname: Anette G.M. surname: Johansson fullname: Johansson, Anette G.M. organization: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden – sequence: 6 givenname: Carl surname: Sellgren fullname: Sellgren, Carl organization: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden – sequence: 7 givenname: Kaj surname: Blennow fullname: Blennow, Kaj organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden – sequence: 8 givenname: Henrik surname: Zetterberg fullname: Zetterberg, Henrik organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden – sequence: 9 givenname: Mikael surname: Landén fullname: Landén, Mikael organization: Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25451615$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/207384$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:131952768$$DView record from Swedish Publication Index |
BookMark | eNqNkk9v1DAQxSNURLeFD8AF5cgliydx1omQkFDFn0qVOABny7Fn29nNxsF2qFbiwzPRLj1UYuGQxJ783jiT9y6ys8EPmGUvQSxBwOrNZtl1tCwFSN4vhYAn2QJEK4oSqvYsW4imaQuoWzjPLmLcCCHqCppn2XlZyxpWUC-yX9eDDWgiutxiwC74ONJg-nzdT-RyGhKGHqctDUXDu7yj0fcm5I6iDw5DPppEOKSYmxi9JZO40z2lu7znG0273AyOr0Rj3Ns7n8jmiQ9MOxY9z56uTR_xxfF5mX3_-OHb1efi5sun66v3N4WtVyoVRnSwhrarZVOtVSlF1bXGSYVSqpWzbc0vVFnxtGC7GkEa45wDZVojXSWq6jIrDn3jPY5Tp8dAOxP22hvSx9KWV6hrUKVqT_K306i5dDvNfClU1UjmXx_4MfgfE8akdxQt9r0Z0E9Rw0oq_veyWv0HWkmeRULD6KsjOnU7dA9f8cc8BuAAWHYtBlw_ICD0HBC90RwQPQdkLnFAWKMeaSwlttAPKRjqTyrfHpTITv0kDDpadt6io4A2aefppPrdI7XtaSBr-i3uMW78FDh1PL-OpRb66xzdObkghZBKKm7Q_r3BPw7_DT6-_wo |
CitedBy_id | crossref_primary_10_1016_j_jpsychires_2017_10_002 crossref_primary_10_18863_pgy_921569 crossref_primary_10_1016_j_psyneuen_2023_106083 crossref_primary_10_1016_j_neulet_2016_05_019 crossref_primary_10_1159_000542888 crossref_primary_10_3390_ijms252413277 crossref_primary_10_3389_fpsyt_2022_863734 crossref_primary_10_1186_s40345_021_00220_w crossref_primary_10_1016_j_jpsychires_2017_03_018 crossref_primary_10_1371_journal_pgen_1006706 crossref_primary_10_1111_jop_12666 crossref_primary_10_1016_j_bbi_2017_05_002 crossref_primary_10_1016_j_bbacli_2016_03_008 crossref_primary_10_3389_fnins_2022_1039379 crossref_primary_10_3390_molecules26082368 crossref_primary_10_1016_j_pnpbp_2017_04_028 crossref_primary_10_1371_journal_pbio_3000353 crossref_primary_10_1186_s12888_022_04079_8 crossref_primary_10_1016_j_pnpbp_2024_111056 crossref_primary_10_1007_s00406_019_01086_x crossref_primary_10_1016_j_psychres_2016_11_017 crossref_primary_10_1016_j_psychres_2017_09_071 crossref_primary_10_1093_schbul_sbx035 crossref_primary_10_1111_bdi_12496 crossref_primary_10_1038_s41398_020_0737_6 crossref_primary_10_32415_jscientia_2024_10_5_28_55 crossref_primary_10_1016_j_bbi_2020_04_013 crossref_primary_10_1016_j_jadr_2022_100368 crossref_primary_10_3389_fpsyt_2018_00614 crossref_primary_10_1016_j_egg_2019_100050 crossref_primary_10_1038_s41380_022_01724_2 crossref_primary_10_1016_j_pnpbp_2020_110173 crossref_primary_10_1038_s41398_024_02921_z crossref_primary_10_1007_s12264_019_00403_7 crossref_primary_10_1074_mcp_R115_053884 crossref_primary_10_3390_pharmaceutics14050901 crossref_primary_10_1016_j_jaut_2019_102339 crossref_primary_10_3390_jpm14050488 crossref_primary_10_1016_j_psychres_2018_09_035 crossref_primary_10_1016_j_euroneuro_2018_04_002 crossref_primary_10_1186_s12888_017_1281_7 crossref_primary_10_1177_1753425915613425 crossref_primary_10_1016_j_ajog_2018_12_015 crossref_primary_10_1038_s41380_023_02073_4 crossref_primary_10_3389_fpsyt_2021_636174 crossref_primary_10_1016_j_euroneuro_2019_07_132 crossref_primary_10_3390_pharmaceutics13111827 crossref_primary_10_1016_j_euroneuro_2020_11_018 crossref_primary_10_1016_j_jad_2020_10_003 crossref_primary_10_1111_jnc_16098 crossref_primary_10_1016_j_jadr_2024_100828 crossref_primary_10_1093_brain_awv266 crossref_primary_10_1038_s41380_018_0220_4 crossref_primary_10_1038_s41398_023_02445_y |
Cites_doi | 10.1016/j.diabres.2012.09.003 10.1001/jama.289.14.1799 10.1016/j.neubiorev.2014.02.001 10.1001/archpsyc.1982.04290080001001 10.1038/mp.2010.52 10.1016/j.jad.2010.02.133 10.1016/S0920-9964(00)00094-3 10.1089/neu.2005.22.822 10.1016/j.ymeth.2012.03.017 10.1016/S0165-0327(98)00025-1 10.1016/j.bbi.2012.06.010 10.1016/j.bbi.2005.12.002 10.1038/jcbfm.2009.240 10.1007/BF02592351 10.1007/s00406-012-0327-6 10.1038/npp.2011.205 10.1016/j.neubiorev.2008.10.005 10.1007/s002130050965 10.1159/000081413 10.1016/j.bbi.2009.04.008 10.1111/j.1360-0443.1993.tb02093.x 10.1016/S0022-3956(99)00021-7 10.1016/S0006-3223(01)01144-1 10.1503/jpn.100080 10.1111/j.1600-0447.2009.01399.x 10.1016/j.jad.2005.11.015 10.1016/j.euroneuro.2007.06.004 10.1017/S0029665110001928 10.1016/j.jad.2012.06.010 10.1176/ajp.154.12.1726 10.1016/j.jpsychires.2013.05.018 10.1016/S0006-3223(03)00165-3 10.1016/j.biopsych.2013.01.007 10.1016/j.jpsychires.2011.08.003 10.1016/j.jad.2007.02.018 10.1007/s00018-013-1459-1 10.1136/jnnp.57.8.897 10.3109/08923973.2013.828744 10.1038/sj.mp.4001084 10.1016/j.intimp.2011.11.011 10.1016/j.psychres.2014.03.045 10.1007/s00213-011-2555-2 10.1097/00004647-199703000-00005 10.4088/JCP.08r04505 10.1074/jbc.M109711200 10.1371/journal.pone.0095192 10.1056/NEJMra035354 10.1038/npp.2012.231 10.1016/j.psychres.2004.08.005 10.1186/1742-2094-9-242 10.1016/S0165-5728(98)00192-1 10.1007/s00406-010-0116-z 10.1016/j.bbi.2011.03.013 10.1097/NEN.0b013e318197eca7 10.4088/JCP.v65n0710 10.1016/S0031-6997(24)01439-X 10.1016/j.psyneuen.2009.06.007 10.1002/jnr.10253 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Inc. Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7QG 7T5 7TK H94 ADTPV AOWAS F1U |
DOI | 10.1016/j.bbi.2014.10.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Animal Behavior Abstracts Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts SwePub SwePub Articles SWEPUB Göteborgs universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Neurosciences Abstracts Animal Behavior Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1090-2139 |
EndPage | 204 |
ExternalDocumentID | oai_swepub_ki_se_517279 oai_gup_ub_gu_se_207384 25451615 10_1016_j_bbi_2014_10_001 S0889159114004747 1_s2_0_S0889159114004747 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM 9JO AAAJQ AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABOYX ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HMQ HVGLF HZ~ IHE J1W KOM L7B LG5 LUGTX LZ5 M2U M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SIN SNS SPCBC SSB SSN SSY SSZ T5K TN5 UAP UNMZH UPT WUQ XPP XSW Z5R ZGI ZMT ~G- ~S- AACTN AFCTW AFKWA AJOXV AMFUW RIG SSI AADPK AAIAV ABYKQ AFYLN AJBFU EFLBG AAYXX ACLOT CITATION ~HD BNPGV CGR CUY CVF ECM EIF NPM SSH 7X8 7QG 7T5 7TK H94 ADTPV AOWAS F1U |
ID | FETCH-LOGICAL-c567t-a0b1f19b5483f72403b9ad47e4476dc955487230881cb5e14aaddd17a9a4d3033 |
IEDL.DBID | .~1 |
ISSN | 0889-1591 1090-2139 |
IngestDate | Tue Sep 30 03:32:45 EDT 2025 Tue Sep 09 23:20:52 EDT 2025 Sun Sep 28 08:03:47 EDT 2025 Sun Sep 28 10:07:31 EDT 2025 Thu Apr 03 07:00:41 EDT 2025 Wed Oct 01 06:31:10 EDT 2025 Thu Apr 24 23:11:25 EDT 2025 Fri Feb 23 02:27:22 EST 2024 Sun Feb 23 10:19:13 EST 2025 Tue Aug 26 16:32:11 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Antipsychotic drugs Cytokines Biomarkers Bipolar disorder Lithium Cerebrospinal fluid Interleukin-8 |
Language | English |
License | Copyright © 2014 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c567t-a0b1f19b5483f72403b9ad47e4476dc955487230881cb5e14aaddd17a9a4d3033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25451615 |
PQID | 1634723418 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_517279 swepub_primary_oai_gup_ub_gu_se_207384 proquest_miscellaneous_1647005436 proquest_miscellaneous_1634723418 pubmed_primary_25451615 crossref_primary_10_1016_j_bbi_2014_10_001 crossref_citationtrail_10_1016_j_bbi_2014_10_001 elsevier_sciencedirect_doi_10_1016_j_bbi_2014_10_001 elsevier_clinicalkeyesjournals_1_s2_0_S0889159114004747 elsevier_clinicalkey_doi_10_1016_j_bbi_2014_10_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Brain, behavior, and immunity |
PublicationTitleAlternate | Brain Behav Immun |
PublicationYear | 2015 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Brietzke, Kauer-Sant’Anna, Teixeira, Kapczinski (b0035) 2009; 23 Barbosa, Rocha, Bauer, de Miranda, Huguet, Reis, Zunszain, Horowitz, Pariante, Teixeira (b0020) 2013; 263 O’Brien, Scully, Scott, Dinan (b0210) 2006; 90 Giovannelli, Limatola, Ragozzino, Mileo, Ruggieri, Ciotti, Mercanti, Santoni, Eusebi (b0085) 1998; 92 Haroon, Raison, Miller (b0105) 2012; 37 Lee, Nagai, Kim (b0150) 2002; 69 Song, Lin, Bonaccorso, Heide, Verkerk, Kenis, Bosmans, Scharpe, Whelan, Cosyns, de Jongh, Maes (b0260) 1998; 49 Rapaport, Manji (b0215) 2001; 50 Dugue, Leppanen, Grasbeck (b0075) 1996; 26 Haack, Hinze-Selch, Fenzel, Kraus, Kuhn, Schuld, Pollmacher (b0095) 1999; 33 Sheehan, Lecrubier, Sheehan, Amorim, Janavs, Weiller, Hergueta, Baker, Dunbar (b0245) 1998; 59 Maes, Bocchio Chiavetto, Bignotti, Battisa Tura, Pioli, Boin, Kenis, Bosmans, de Jongh, Altamura (b0160) 2002; 54 Maier, Laurer, Rose, Buurman, Marzi (b0170) 2005; 22 Modabbernia, Taslimi, Brietzke, Ashrafi (b0185) 2013; 74 Saunders, Aasland, Babor, de la Fuente, Grant (b0235) 1993; 88 Zhang, Zhou, Cao, Zhang, Wu, Shen (b0295) 2004; 65 Cruz, Sousa, Sousa, Pietrani, Fernandes, Gomes (b0055) 2013; 99 Di Nicola, Cattaneo, Hepgul, Di Forti, Aitchison, Janiri, Murray, Dazzan, Pariante, Mondelli (b0065) 2013; 31 Semple, Kossmann, Morganti-Kossmann (b0240) 2010; 30 Hallberg, Janelidze, Engstrom, Wisen, Westrin, Brundin (b0100) 2010; 126 Söderlund, Olsson, Samuelsson, Walther-Jallow, Johansson, Erhardt, Landen, Engberg (b0275) 2011; 36 Munkholm, Vinberg, Vedel Kessing (b0195) 2013; 144 Roy, Lanctot, Merette, Cliche, Fournier, Boutin, Rodrigue, Charron, Turgeon, Hamel, Montgrain, Nicole, Pires, Wallot, Ponton, Garneau, Dion, Lavallee, Potvin, Szatmari, Maziade (b0220) 1997; 154 Esposito, Pontillo, Di Palo, Giugliano, Masella, Marfella, Giugliano (b0080) 2003; 289 Sachs, Thase, Otto, Bauer, Miklowitz, Wisniewski, Lavori, Lebowitz, Rudorfer, Frank, Nierenberg, Fava, Bowden, Ketter, Marangell, Calabrese, Kupfer, Rosenbaum (b0230) 2003; 53 Shelton, Claiborne, Sidoryk-Wegrzynowicz, Reddy, Aschner, Lewis, Mirnics (b0250) 2011; 16 Yao, Tsirka (b0285) 2014; 71 Kossmann, Stahel, Lenzlinger, Redl, Dubs, Trentz, Schlag, Morganti-Kossmann (b0140) 1997; 17 Stuart, Baune (b0265) 2014; 42 Lehto, Niskanen, Herzig, Tolmunen, Huotari, Viinamaki, Koivumaa-Honkanen, Honkalampi, Ruotsalainen, Hintikka (b0155) 2010; 35 Malekzadeh, de Groot, Beckerman, van Oosten, Blankenstein, Teunissen (b0175) 2012; 56 Kim, Jung, Myint, Kim, Park (b0120) 2007; 104 Subileau, Rezaie, Davies, Colyer, Greenwood, Male, Romero (b0270) 2009; 68 Leckman, Sholomskas, Thompson, Belanger, Weissman (b0145) 1982; 39 Nemeth, Deitch, Szabo, Fekete, Hauser, Hasko (b0205) 2002; 277 Bromander, Anckarsater, Kristiansson, Blennow, Zetterberg, Anckarsater, Wass (b0040) 2012; 9 Munkholm, Brauner, Kessing, Vinberg (b0190) 2013; 47 Hope, Dieset, Agartz, Steen, Ueland, Melle, Aukrust, Andreassen (b0110) 2011; 45 Murphy, Baggiolini, Charo, Hebert, Horuk, Matsushima, Miller, Oppenheim, Power (b0200) 2000; 52 Berman, Bergman, Palmstierna, Schlyter (b0030) 2005; 11 Maes, Song, Lin, Pioli, Kenis, Kubera, Bosmans (b0165) 1999; 143 Jakobsson, Zetterberg, Blennow, Johan Ekman, Johansson, Landen (b0115) 2013; 38 Goldstein, Kemp, Soczynska, McIntyre (b0090) 2009; 70 Kim, Suh, Kim, Han, Lim, Choi, Licinio (b0130) 2002; 7 Davey, O’Mahony, Schellekens, O’Sullivan, Bienenstock, Cotter, Dinan, Cryan (b0060) 2012; 221 Chen, Wu, Tsai, Wang, Tsai (b0050) 2013; 35 Andersson, Alvarez-Cermeno, Bernardi, Cogato, Fredman, Frederiksen, Fredrikson, Gallo, Grimaldi, Gronning (b0005) 1994; 57 Zetterberg, Jakobsson, Redsater, Andreasson, Palsson, Ekman, Sellgren, Johansson, Blennow, Landen (b0290) 2014; 217 Belmaker (b0025) 2004; 351 Ryden, Thase, Straht, Aberg-Wistedt, Bejerot, Landen (b0225) 2009; 120 Simon, McNamara, Chow, Maser, Papakostas, Pollack, Nierenberg, Fava, Wong (b0255) 2008; 18 Chen, Tsai, Wang, Lin, Tsai, Lee, Tsai (b0045) 2012; 12 McAfoose, Baune (b0180) 2009; 33 Assarson, Lundberg, Holmquist, Björkesten, Thorsen, Ekman, Eriksson, Rennel Dickens, Ohlsson, Edfeldt, Andersson, Lindstedt, Stenvang, Gullberg, Fredriksson (b0010) 2014; 9 Barbosa, Huguet, Mendonca, Sousa, Neves, Bauer, Teixeira (b0015) 2011; 261 Kim, Myint, Lee, Han, Lee, Leonard, Steinbusch (b0125) 2004; 129 Kohut, McCann, Russell, Konopka, Cunnick, Franke, Castillo, Reighard, Vanderah (b0135) 2006; 20 Warnberg, Cunningham, Romeo, Marcos (b0280) 2010; 69 Drexhage, Hoogenboezem, Versnel, Berghout, Nolen, Drexhage (b0070) 2011; 25 Stuart (10.1016/j.bbi.2014.10.001_b0265) 2014; 42 Kossmann (10.1016/j.bbi.2014.10.001_b0140) 1997; 17 McAfoose (10.1016/j.bbi.2014.10.001_b0180) 2009; 33 Rapaport (10.1016/j.bbi.2014.10.001_b0215) 2001; 50 Brietzke (10.1016/j.bbi.2014.10.001_b0035) 2009; 23 Munkholm (10.1016/j.bbi.2014.10.001_b0195) 2013; 144 Roy (10.1016/j.bbi.2014.10.001_b0220) 1997; 154 Zetterberg (10.1016/j.bbi.2014.10.001_b0290) 2014; 217 Söderlund (10.1016/j.bbi.2014.10.001_b0275) 2011; 36 Belmaker (10.1016/j.bbi.2014.10.001_b0025) 2004; 351 Esposito (10.1016/j.bbi.2014.10.001_b0080) 2003; 289 Yao (10.1016/j.bbi.2014.10.001_b0285) 2014; 71 Barbosa (10.1016/j.bbi.2014.10.001_b0020) 2013; 263 Song (10.1016/j.bbi.2014.10.001_b0260) 1998; 49 Jakobsson (10.1016/j.bbi.2014.10.001_b0115) 2013; 38 Bromander (10.1016/j.bbi.2014.10.001_b0040) 2012; 9 Giovannelli (10.1016/j.bbi.2014.10.001_b0085) 1998; 92 Subileau (10.1016/j.bbi.2014.10.001_b0270) 2009; 68 Andersson (10.1016/j.bbi.2014.10.001_b0005) 1994; 57 Ryden (10.1016/j.bbi.2014.10.001_b0225) 2009; 120 Kim (10.1016/j.bbi.2014.10.001_b0130) 2002; 7 Chen (10.1016/j.bbi.2014.10.001_b0045) 2012; 12 Di Nicola (10.1016/j.bbi.2014.10.001_b0065) 2013; 31 Davey (10.1016/j.bbi.2014.10.001_b0060) 2012; 221 Barbosa (10.1016/j.bbi.2014.10.001_b0015) 2011; 261 Hope (10.1016/j.bbi.2014.10.001_b0110) 2011; 45 Murphy (10.1016/j.bbi.2014.10.001_b0200) 2000; 52 Semple (10.1016/j.bbi.2014.10.001_b0240) 2010; 30 Shelton (10.1016/j.bbi.2014.10.001_b0250) 2011; 16 Zhang (10.1016/j.bbi.2014.10.001_b0295) 2004; 65 Berman (10.1016/j.bbi.2014.10.001_b0030) 2005; 11 Modabbernia (10.1016/j.bbi.2014.10.001_b0185) 2013; 74 Simon (10.1016/j.bbi.2014.10.001_b0255) 2008; 18 Maier (10.1016/j.bbi.2014.10.001_b0170) 2005; 22 Chen (10.1016/j.bbi.2014.10.001_b0050) 2013; 35 Maes (10.1016/j.bbi.2014.10.001_b0165) 1999; 143 Haroon (10.1016/j.bbi.2014.10.001_b0105) 2012; 37 Goldstein (10.1016/j.bbi.2014.10.001_b0090) 2009; 70 Munkholm (10.1016/j.bbi.2014.10.001_b0190) 2013; 47 Dugue (10.1016/j.bbi.2014.10.001_b0075) 1996; 26 Lee (10.1016/j.bbi.2014.10.001_b0150) 2002; 69 Saunders (10.1016/j.bbi.2014.10.001_b0235) 1993; 88 Warnberg (10.1016/j.bbi.2014.10.001_b0280) 2010; 69 O’Brien (10.1016/j.bbi.2014.10.001_b0210) 2006; 90 Haack (10.1016/j.bbi.2014.10.001_b0095) 1999; 33 Kim (10.1016/j.bbi.2014.10.001_b0120) 2007; 104 Malekzadeh (10.1016/j.bbi.2014.10.001_b0175) 2012; 56 Drexhage (10.1016/j.bbi.2014.10.001_b0070) 2011; 25 Sachs (10.1016/j.bbi.2014.10.001_b0230) 2003; 53 Cruz (10.1016/j.bbi.2014.10.001_b0055) 2013; 99 Lehto (10.1016/j.bbi.2014.10.001_b0155) 2010; 35 Sheehan (10.1016/j.bbi.2014.10.001_b0245) 1998; 59 Maes (10.1016/j.bbi.2014.10.001_b0160) 2002; 54 Assarson (10.1016/j.bbi.2014.10.001_b0010) 2014; 9 Kohut (10.1016/j.bbi.2014.10.001_b0135) 2006; 20 Leckman (10.1016/j.bbi.2014.10.001_b0145) 1982; 39 Kim (10.1016/j.bbi.2014.10.001_b0125) 2004; 129 Nemeth (10.1016/j.bbi.2014.10.001_b0205) 2002; 277 Hallberg (10.1016/j.bbi.2014.10.001_b0100) 2010; 126 |
References_xml | – volume: 23 start-page: 1079 year: 2009 end-page: 1082 ident: b0035 article-title: Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder publication-title: Brain Behav. Immun. – volume: 261 start-page: 139 year: 2011 end-page: 143 ident: b0015 article-title: Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder publication-title: Eur. Arch. Psychiatry Clin. Neurosci. – volume: 30 start-page: 459 year: 2010 end-page: 473 ident: b0240 article-title: Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks publication-title: J. Cereb. Blood Flow Metab. – volume: 126 start-page: 262 year: 2010 end-page: 267 ident: b0100 article-title: Exercise-induced release of cytokines in patients with major depressive disorder publication-title: J. Affect. Disord. – volume: 92 start-page: 122 year: 1998 end-page: 132 ident: b0085 article-title: CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum publication-title: J. Neuroimmunol. – volume: 263 start-page: 159 year: 2013 end-page: 165 ident: b0020 article-title: Chemokines in bipolar disorder: trait or state? publication-title: Eur. Arch. Psychiatry Clin. Neurosci. – volume: 26 start-page: 99 year: 1996 end-page: 105 ident: b0075 article-title: Preanalytical factors and the measurement of cytokines in human subjects publication-title: Int J Clin Lab. Res. – volume: 36 start-page: 114 year: 2011 end-page: 118 ident: b0275 article-title: Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder publication-title: J. Psychiatry Neurosci. – volume: 35 start-page: 573 year: 2013 end-page: 580 ident: b0050 article-title: Regulation of macrophage immune responses by antipsychotic drugs publication-title: Immunopharmacol. Immunotoxicol. – volume: 104 start-page: 91 year: 2007 end-page: 95 ident: b0120 article-title: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder publication-title: J. Affect. Disord. – volume: 33 start-page: 355 year: 2009 end-page: 366 ident: b0180 article-title: Evidence for a cytokine model of cognitive function publication-title: Neurosci. Biobehav. Rev. – volume: 16 start-page: 751 year: 2011 end-page: 762 ident: b0250 article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression publication-title: Mol. Psychiatry – volume: 12 start-page: 197 year: 2012 end-page: 204 ident: b0045 article-title: Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils publication-title: Int. Immunopharmacol. – volume: 17 start-page: 280 year: 1997 end-page: 289 ident: b0140 article-title: Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production publication-title: J. Cereb. Blood Flow Metab. – volume: 217 start-page: 143 year: 2014 end-page: 146 ident: b0290 article-title: Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment publication-title: Psychiatry Res. – volume: 69 start-page: 400 year: 2010 end-page: 406 ident: b0280 article-title: Physical activity, exercise and low-grade systemic inflammation publication-title: Proc. Nutr. Soc. – volume: 7 start-page: 1107 year: 2002 end-page: 1114 ident: b0130 article-title: The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs publication-title: Mol. Psychiatry – volume: 221 start-page: 155 year: 2012 end-page: 169 ident: b0060 article-title: Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters publication-title: Psychopharmacology – volume: 74 start-page: 15 year: 2013 end-page: 25 ident: b0185 article-title: Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies publication-title: Biol. Psychiatry – volume: 49 start-page: 211 year: 1998 end-page: 219 ident: b0260 article-title: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression publication-title: J. Affect. Disord. – volume: 57 start-page: 897 year: 1994 end-page: 902 ident: b0005 article-title: Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 71 start-page: 683 year: 2014 end-page: 697 ident: b0285 article-title: Monocyte chemoattractant protein-1 and the blood–brain barrier publication-title: Cell. Mol. Life Sci. – volume: 56 start-page: 508 year: 2012 end-page: 513 ident: b0175 article-title: Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases (San Diego, Calif.) publication-title: Methods – volume: 38 start-page: 664 year: 2013 end-page: 672 ident: b0115 article-title: Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder publication-title: Neuropsychopharmacology – volume: 144 start-page: 16 year: 2013 end-page: 27 ident: b0195 article-title: Cytokines in bipolar disorder: a systematic review and meta-analysis publication-title: J. Affect. Disord. – volume: 20 start-page: 201 year: 2006 end-page: 209 ident: b0135 article-title: Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults publication-title: Brain Behav. Immun. – volume: 70 start-page: 1078 year: 2009 end-page: 1090 ident: b0090 article-title: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature publication-title: J. Clin. Psychiatry – volume: 65 start-page: 940 year: 2004 end-page: 947 ident: b0295 article-title: Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia publication-title: J. Clin. Psychiatry – volume: 68 start-page: 227 year: 2009 end-page: 240 ident: b0270 article-title: Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis publication-title: J. Neuropathol. Exp. Neurol. – volume: 50 start-page: 217 year: 2001 end-page: 224 ident: b0215 article-title: The effects of lithium on ex vivo cytokine production publication-title: Biol. Psychiatry – volume: 25 start-page: 1206 year: 2011 end-page: 1213 ident: b0070 article-title: The activation of monocyte and T cell networks in patients with bipolar disorder publication-title: Brain Behav. Immun. – volume: 129 start-page: 267 year: 2004 end-page: 272 ident: b0125 article-title: T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients publication-title: Psychiatry Res. – volume: 143 start-page: 401 year: 1999 end-page: 407 ident: b0165 article-title: In vitro immunoregulatory effects of lithium in healthy volunteers publication-title: Psychopharmacology – volume: 90 start-page: 263 year: 2006 end-page: 267 ident: b0210 article-title: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients publication-title: J. Affect. Disord. – volume: 277 start-page: 7713 year: 2002 end-page: 7719 ident: b0205 article-title: Lithium induces NF-kappa B activation and interleukin-8 production in human intestinal epithelial cells publication-title: J. Biol. Chem. – volume: 9 start-page: e95192 year: 2014 ident: b0010 article-title: Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability publication-title: PLoS ONE – volume: 22 start-page: 822 year: 2005 end-page: 835 ident: b0170 article-title: Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study publication-title: J. Neurotrauma – volume: 99 start-page: 85 year: 2013 end-page: 92 ident: b0055 article-title: The linkage between inflammation and Type 2 diabetes mellitus publication-title: Diabetes Res. Clin. Pract. – volume: 47 start-page: 1119 year: 2013 end-page: 1133 ident: b0190 article-title: Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis publication-title: J. Psychiatr. Res. – volume: 35 start-page: 226 year: 2010 end-page: 232 ident: b0155 article-title: Serum chemokine levels in major depressive disorder publication-title: Psychoneuroendocrinology – volume: 154 start-page: 1726 year: 1997 end-page: 1733 ident: b0220 article-title: Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure publication-title: Am. J. Psychiatry – volume: 59 start-page: 22 year: 1998 end-page: 33 ident: b0245 article-title: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 publication-title: J. Clin. Psychiatry – volume: 33 start-page: 407 year: 1999 end-page: 418 ident: b0095 article-title: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis publication-title: J. Psychiatr. Res. – volume: 53 start-page: 1028 year: 2003 end-page: 1042 ident: b0230 article-title: Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) publication-title: Biol. Psychiatry – volume: 31 start-page: 90 year: 2013 end-page: 95 ident: b0065 article-title: Serum and gene expression profile of cytokines in first-episode psychosis publication-title: Brain Behav. Immun. – volume: 351 start-page: 476 year: 2004 end-page: 486 ident: b0025 article-title: Bipolar disorder publication-title: N. Engl. J. Med. – volume: 9 start-page: 242 year: 2012 ident: b0040 article-title: Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study publication-title: J. Neuroinflammation – volume: 39 start-page: 879 year: 1982 end-page: 883 ident: b0145 article-title: Best estimate of lifetime psychiatric diagnosis: a methodological study publication-title: Arch. Gen. Psychiatry – volume: 120 start-page: 239 year: 2009 end-page: 246 ident: b0225 article-title: A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD publication-title: Acta Psychiatr. Scand. – volume: 289 start-page: 1799 year: 2003 end-page: 1804 ident: b0080 article-title: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial publication-title: JAMA – volume: 54 start-page: 281 year: 2002 end-page: 291 ident: b0160 article-title: Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor publication-title: Schizophr. Res. – volume: 88 start-page: 791 year: 1993 end-page: 804 ident: b0235 article-title: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II publication-title: Addiction – volume: 52 start-page: 145 year: 2000 end-page: 176 ident: b0200 article-title: International union of pharmacology. XXII. Nomenclature for chemokine receptors publication-title: Pharmacol. Rev. – volume: 42 start-page: 93 year: 2014 end-page: 115 ident: b0265 article-title: Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies publication-title: Neurosci. Biobehav. Rev. – volume: 18 start-page: 230 year: 2008 end-page: 233 ident: b0255 article-title: A detailed examination of cytokine abnormalities in Major Depressive Disorder publication-title: Eur. Neuropsychopharmacol. – volume: 69 start-page: 94 year: 2002 end-page: 103 ident: b0150 article-title: Cytokines, chemokines, and cytokine receptors in human microglia publication-title: J. Neurosci. Res. – volume: 11 start-page: 22 year: 2005 end-page: 31 ident: b0030 article-title: Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample publication-title: Eur. Addict. Res. – volume: 37 start-page: 137 year: 2012 end-page: 162 ident: b0105 article-title: Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior publication-title: Neuropsychopharmacology – volume: 45 start-page: 1608 year: 2011 end-page: 1616 ident: b0110 article-title: Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia publication-title: J. Psychiatr. Res. – volume: 99 start-page: 85 issue: 2 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0055 article-title: The linkage between inflammation and Type 2 diabetes mellitus publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2012.09.003 – volume: 289 start-page: 1799 year: 2003 ident: 10.1016/j.bbi.2014.10.001_b0080 article-title: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial publication-title: JAMA doi: 10.1001/jama.289.14.1799 – volume: 42 start-page: 93 year: 2014 ident: 10.1016/j.bbi.2014.10.001_b0265 article-title: Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2014.02.001 – volume: 39 start-page: 879 year: 1982 ident: 10.1016/j.bbi.2014.10.001_b0145 article-title: Best estimate of lifetime psychiatric diagnosis: a methodological study publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1982.04290080001001 – volume: 16 start-page: 751 year: 2011 ident: 10.1016/j.bbi.2014.10.001_b0250 article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression publication-title: Mol. Psychiatry doi: 10.1038/mp.2010.52 – volume: 126 start-page: 262 year: 2010 ident: 10.1016/j.bbi.2014.10.001_b0100 article-title: Exercise-induced release of cytokines in patients with major depressive disorder publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2010.02.133 – volume: 54 start-page: 281 year: 2002 ident: 10.1016/j.bbi.2014.10.001_b0160 article-title: Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor publication-title: Schizophr. Res. doi: 10.1016/S0920-9964(00)00094-3 – volume: 22 start-page: 822 year: 2005 ident: 10.1016/j.bbi.2014.10.001_b0170 article-title: Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study publication-title: J. Neurotrauma doi: 10.1089/neu.2005.22.822 – volume: 56 start-page: 508 year: 2012 ident: 10.1016/j.bbi.2014.10.001_b0175 article-title: Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases (San Diego, Calif.) publication-title: Methods doi: 10.1016/j.ymeth.2012.03.017 – volume: 49 start-page: 211 year: 1998 ident: 10.1016/j.bbi.2014.10.001_b0260 article-title: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression publication-title: J. Affect. Disord. doi: 10.1016/S0165-0327(98)00025-1 – volume: 31 start-page: 90 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0065 article-title: Serum and gene expression profile of cytokines in first-episode psychosis publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2012.06.010 – volume: 20 start-page: 201 year: 2006 ident: 10.1016/j.bbi.2014.10.001_b0135 article-title: Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2005.12.002 – volume: 30 start-page: 459 year: 2010 ident: 10.1016/j.bbi.2014.10.001_b0240 article-title: Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2009.240 – volume: 26 start-page: 99 year: 1996 ident: 10.1016/j.bbi.2014.10.001_b0075 article-title: Preanalytical factors and the measurement of cytokines in human subjects publication-title: Int J Clin Lab. Res. doi: 10.1007/BF02592351 – volume: 263 start-page: 159 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0020 article-title: Chemokines in bipolar disorder: trait or state? publication-title: Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s00406-012-0327-6 – volume: 37 start-page: 137 year: 2012 ident: 10.1016/j.bbi.2014.10.001_b0105 article-title: Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.205 – volume: 33 start-page: 355 year: 2009 ident: 10.1016/j.bbi.2014.10.001_b0180 article-title: Evidence for a cytokine model of cognitive function publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2008.10.005 – volume: 143 start-page: 401 year: 1999 ident: 10.1016/j.bbi.2014.10.001_b0165 article-title: In vitro immunoregulatory effects of lithium in healthy volunteers publication-title: Psychopharmacology doi: 10.1007/s002130050965 – volume: 11 start-page: 22 year: 2005 ident: 10.1016/j.bbi.2014.10.001_b0030 article-title: Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample publication-title: Eur. Addict. Res. doi: 10.1159/000081413 – volume: 23 start-page: 1079 year: 2009 ident: 10.1016/j.bbi.2014.10.001_b0035 article-title: Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2009.04.008 – volume: 88 start-page: 791 year: 1993 ident: 10.1016/j.bbi.2014.10.001_b0235 article-title: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption—II publication-title: Addiction doi: 10.1111/j.1360-0443.1993.tb02093.x – volume: 33 start-page: 407 year: 1999 ident: 10.1016/j.bbi.2014.10.001_b0095 article-title: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis publication-title: J. Psychiatr. Res. doi: 10.1016/S0022-3956(99)00021-7 – volume: 50 start-page: 217 year: 2001 ident: 10.1016/j.bbi.2014.10.001_b0215 article-title: The effects of lithium on ex vivo cytokine production publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(01)01144-1 – volume: 36 start-page: 114 year: 2011 ident: 10.1016/j.bbi.2014.10.001_b0275 article-title: Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder publication-title: J. Psychiatry Neurosci. doi: 10.1503/jpn.100080 – volume: 120 start-page: 239 year: 2009 ident: 10.1016/j.bbi.2014.10.001_b0225 article-title: A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD publication-title: Acta Psychiatr. Scand. doi: 10.1111/j.1600-0447.2009.01399.x – volume: 90 start-page: 263 year: 2006 ident: 10.1016/j.bbi.2014.10.001_b0210 article-title: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2005.11.015 – volume: 18 start-page: 230 year: 2008 ident: 10.1016/j.bbi.2014.10.001_b0255 article-title: A detailed examination of cytokine abnormalities in Major Depressive Disorder publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2007.06.004 – volume: 69 start-page: 400 year: 2010 ident: 10.1016/j.bbi.2014.10.001_b0280 article-title: Physical activity, exercise and low-grade systemic inflammation publication-title: Proc. Nutr. Soc. doi: 10.1017/S0029665110001928 – volume: 144 start-page: 16 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0195 article-title: Cytokines in bipolar disorder: a systematic review and meta-analysis publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2012.06.010 – volume: 154 start-page: 1726 year: 1997 ident: 10.1016/j.bbi.2014.10.001_b0220 article-title: Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure publication-title: Am. J. Psychiatry doi: 10.1176/ajp.154.12.1726 – volume: 47 start-page: 1119 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0190 article-title: Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2013.05.018 – volume: 53 start-page: 1028 year: 2003 ident: 10.1016/j.bbi.2014.10.001_b0230 article-title: Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(03)00165-3 – volume: 74 start-page: 15 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0185 article-title: Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.01.007 – volume: 45 start-page: 1608 year: 2011 ident: 10.1016/j.bbi.2014.10.001_b0110 article-title: Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2011.08.003 – volume: 104 start-page: 91 year: 2007 ident: 10.1016/j.bbi.2014.10.001_b0120 article-title: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2007.02.018 – volume: 71 start-page: 683 year: 2014 ident: 10.1016/j.bbi.2014.10.001_b0285 article-title: Monocyte chemoattractant protein-1 and the blood–brain barrier publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-013-1459-1 – volume: 57 start-page: 897 year: 1994 ident: 10.1016/j.bbi.2014.10.001_b0005 article-title: Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.57.8.897 – volume: 35 start-page: 573 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0050 article-title: Regulation of macrophage immune responses by antipsychotic drugs publication-title: Immunopharmacol. Immunotoxicol. doi: 10.3109/08923973.2013.828744 – volume: 7 start-page: 1107 year: 2002 ident: 10.1016/j.bbi.2014.10.001_b0130 article-title: The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4001084 – volume: 12 start-page: 197 year: 2012 ident: 10.1016/j.bbi.2014.10.001_b0045 article-title: Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2011.11.011 – volume: 217 start-page: 143 year: 2014 ident: 10.1016/j.bbi.2014.10.001_b0290 article-title: Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2014.03.045 – volume: 221 start-page: 155 year: 2012 ident: 10.1016/j.bbi.2014.10.001_b0060 article-title: Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters publication-title: Psychopharmacology doi: 10.1007/s00213-011-2555-2 – volume: 17 start-page: 280 year: 1997 ident: 10.1016/j.bbi.2014.10.001_b0140 article-title: Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production publication-title: J. Cereb. Blood Flow Metab. doi: 10.1097/00004647-199703000-00005 – volume: 70 start-page: 1078 year: 2009 ident: 10.1016/j.bbi.2014.10.001_b0090 article-title: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.08r04505 – volume: 277 start-page: 7713 year: 2002 ident: 10.1016/j.bbi.2014.10.001_b0205 article-title: Lithium induces NF-kappa B activation and interleukin-8 production in human intestinal epithelial cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109711200 – volume: 9 start-page: e95192 issue: 4 year: 2014 ident: 10.1016/j.bbi.2014.10.001_b0010 article-title: Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability publication-title: PLoS ONE doi: 10.1371/journal.pone.0095192 – volume: 351 start-page: 476 year: 2004 ident: 10.1016/j.bbi.2014.10.001_b0025 article-title: Bipolar disorder publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra035354 – volume: 38 start-page: 664 year: 2013 ident: 10.1016/j.bbi.2014.10.001_b0115 article-title: Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder publication-title: Neuropsychopharmacology doi: 10.1038/npp.2012.231 – volume: 129 start-page: 267 year: 2004 ident: 10.1016/j.bbi.2014.10.001_b0125 article-title: T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2004.08.005 – volume: 9 start-page: 242 year: 2012 ident: 10.1016/j.bbi.2014.10.001_b0040 article-title: Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study publication-title: J. Neuroinflammation doi: 10.1186/1742-2094-9-242 – volume: 92 start-page: 122 year: 1998 ident: 10.1016/j.bbi.2014.10.001_b0085 article-title: CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(98)00192-1 – volume: 261 start-page: 139 year: 2011 ident: 10.1016/j.bbi.2014.10.001_b0015 article-title: Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder publication-title: Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s00406-010-0116-z – volume: 25 start-page: 1206 year: 2011 ident: 10.1016/j.bbi.2014.10.001_b0070 article-title: The activation of monocyte and T cell networks in patients with bipolar disorder publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2011.03.013 – volume: 68 start-page: 227 year: 2009 ident: 10.1016/j.bbi.2014.10.001_b0270 article-title: Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e318197eca7 – volume: 65 start-page: 940 year: 2004 ident: 10.1016/j.bbi.2014.10.001_b0295 article-title: Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v65n0710 – volume: 52 start-page: 145 year: 2000 ident: 10.1016/j.bbi.2014.10.001_b0200 article-title: International union of pharmacology. XXII. Nomenclature for chemokine receptors publication-title: Pharmacol. Rev. doi: 10.1016/S0031-6997(24)01439-X – volume: 59 start-page: 22 issue: Suppl. 20 year: 1998 ident: 10.1016/j.bbi.2014.10.001_b0245 article-title: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 publication-title: J. Clin. Psychiatry – volume: 35 start-page: 226 year: 2010 ident: 10.1016/j.bbi.2014.10.001_b0155 article-title: Serum chemokine levels in major depressive disorder publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.06.007 – volume: 69 start-page: 94 year: 2002 ident: 10.1016/j.bbi.2014.10.001_b0150 article-title: Cytokines, chemokines, and cytokine receptors in human microglia publication-title: J. Neurosci. Res. doi: 10.1002/jnr.10253 |
SSID | ssj0005318 |
Score | 2.351688 |
Snippet | •Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls.•Higher IL-8 concentrations associated to lithium- and antipsychotic... Highlights • Higher CSF IL-8 concentrations in bipolar disorder patients as compared to controls. • Higher IL-8 concentrations associated to lithium- and... Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma... |
SourceID | swepub proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 198 |
SubjectTerms | Adult Allergy and Immunology Antimanic Agents - therapeutic use Antipsychotic Agents - therapeutic use Antipsychotic drugs Biomarkers Bipolar disorder Bipolar Disorder - cerebrospinal fluid Bipolar Disorder - drug therapy Cerebrospinal fluid Cytokines Female Humans Interleukin-8 Interleukin-8 - cerebrospinal fluid Lithium Lithium - therapeutic use Male Middle Aged Neurosciences Neurovetenskaper Psychiatry |
Title | Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0889159114004747 https://www.clinicalkey.es/playcontent/1-s2.0-S0889159114004747 https://dx.doi.org/10.1016/j.bbi.2014.10.001 https://www.ncbi.nlm.nih.gov/pubmed/25451615 https://www.proquest.com/docview/1634723418 https://www.proquest.com/docview/1647005436 https://gup.ub.gu.se/publication/207384 http://kipublications.ki.se/Default.aspx?queryparsed=id:131952768 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1090-2139 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005318 issn: 0889-1591 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1090-2139 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005318 issn: 0889-1591 databaseCode: .~1 dateStart: 0 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1090-2139 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005318 issn: 0889-1591 databaseCode: ACRLP dateStart: 19950301 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1090-2139 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005318 issn: 0889-1591 databaseCode: AIKHN dateStart: 19950301 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1090-2139 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005318 issn: 0889-1591 databaseCode: AKRWK dateStart: 19930301 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJLaZM-3EdQoeRQcNayZcs-LkvD9hVK20BuQi8nbjbOsl4fAqG_vTO2bNom3UIPy2LtyPZqRqMZ6dMnQl5zbh2zJQutSE3IE-iKKjcmVAKjkSLOctexfR5l82P-_iQ92SKzYS8Mwiq97-99euetfcnEt-ZkWVWTrwjQgcEYAnqkPOS4oxzZv8CmD378AvPo5_g6NA9KDyubHcZL6wrRXfygA3ixv41NN2PPP4hFu8Ho8AG576NIOu1f9CHZcvUO2Z3WkEFfXNF92uE6uwnzHXL3k18-3yXX4A0QhO4sNW4F2TAeGoI3KhdtZSlSR6wWrj2v6jCHK6qrJWa-1HqKTupZWBuqvFbhTjiTSyGYP6vaC6pqC5915Td3VYaOSPZH5Pjw7bfZPPTHL4QmzcQ6VJFmJSs05DRJKZC3TxfKcuE4F5k1RYrJDmQwec6MTh3jCnylZUIVilsYGZPHZLu-rN1TQg0oQTCrk6x0XEUqR96jRFhh4yjWcRGQaGh4aTw3OR6RsZADCO27BF1J1BUWga4C8massuyJOTYJx4M25bDjFHykhGFjUyVxWyXX-F7eSCabWEbyhiUGhI81fzPmfz3w1WBoEjo5rtyo2l228KAs4dDUnOWbZLjAADzJAvKkt9KxYeIUz2NmaUD2e7Mdf0F28dN2KaHotJWNg_cRSc5vF_RF5xUKphj6Fs_-768-J_fgKu3nsl6Q7fWqdS8hulvrva777pE709mXj5_x-92H-dFPpCxRBA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrQRcELQ8wtNIqAeksHHixMlxVVFtabsXWqk3y4mdNnSbrnY3ByR-PDOJEwQti8RhD-t48vDY87A_fwb4IISx3JTcNzIufBHhUNRpUfhaUjSShUlqW7bPWTI9E1_O4_Mt2O_3whCs0tn-zqa31tqVjF1rjhdVNf5KAB10xhjQE-WhkPdgW8Rok0ewPTk8ms5-IT26ab4W0EMC_eJmC_PK84oAXuJTi_Hif3NPt8PPP7hFW3908BgeuUCSTbp3fQJbtt6B3UmNSfT1d7bHWmhnO2e-A_dP3Ar6LvxAg0A4dGtYYZeYENO5IXSjct5UhhF7xHJum6uq9lP8x_JqQckvM46lkzki1hXTTrF4J5rMZRjPX1bNNdO1wd-6cvu7qoINYPancHbw-XR_6rsTGPwiTuTa10HOS57lmNZEpSTqvjzTRkgrhExMkcWU72ASk6a8yGPLhUZzabjUmRYGnWP0DEb1TW1fACtQCZKbPEpKK3SgU6I-iqSRJgzCPMw8CPqGV4WjJ6dTMuaqx6F9U6grRbqiItSVBx8HkUXHzbGpcthrU_WbTtFMKvQcm4TkXUJ25Qb6SnG1ClWgbnVGD8Qg-Vt__tcD3_cdTeE4p8UbXdubBh-URAKbWvB0Ux0hKQaPEg-ed710aJgwpiOZeezBXtdthytEMH7RLBQWXTRqZfF9ZJSKuyu6oquKKsYU_WYv_-9T38GD6enJsTo-nB29god4Je6mtl7DaL1s7BsM9tb5WzeYfwJfHFIa |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+cerebrospinal+fluid+interleukin-8+in+bipolar+disorder+patients+associated+with+lithium+and+antipsychotic+treatment&rft.jtitle=Brain%2C+behavior%2C+and+immunity&rft.au=Isgren%2C+Anniella&rft.au=Jakobsson%2C+Joel&rft.au=P%C3%A5lsson%2C+Erik&rft.au=Ekman%2C+Carl+Johan&rft.date=2015-01-01&rft.issn=0889-1591&rft.volume=43&rft.spage=198&rft.epage=204&rft_id=info:doi/10.1016%2Fj.bbi.2014.10.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbi_2014_10_001 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08891591%2FS0889159114X00097%2Fcov150h.gif |